FDA Approves Unknown Drug — TORRENT

# FDA Approves Torrent Pharmaceutical's ANDA Application Torrent Pharmaceuticals received FDA approval for ANDA213405 on August 3, 2023, expanding its generic drug portfolio and positioning the company to capture additional market share in the competitive generic pharmaceutical sector. The approval strengthens Torrent's U.S. market presence and could contribute to revenue growth as the company continues to build its pipeline of bioequivalent generic formulations.